|
Quotes & Info
|
| ARIA > SEC Filings for ARIA > Form 8-K on 29-Jan-2013 | All Recent SEC Filings |
29-Jan-2013
Other Events, Financial Statements and Exhibits
On January 29, 2013, ARIAD Pharmaceuticals, Inc. ("ARIAD") issued a press release announcing the completion of its previously announced public offering of 15,307,000 shares of common stock at a public offering price of $19.60 per share. In addition, ARIAD announced that the underwriters have exercised an option to purchase an additional 1,182,893 shares at $19.60 per share to cover over-allotments. The total gross proceeds from the offering are approximately $323 million. Net proceeds to ARIAD are approximately $310 million after deducting underwriting discounts and commissions and estimated offering expenses.
(d) The following exhibit is filed with this report:
Exhibit Number Description 99.1 Press Release dated January 29, 2013. |
|
|